These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 18292096)

  • 21. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility].
    She D; Liu Y
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1355-8. PubMed ID: 12509943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
    Messai Y; Iabadene H; Benhassine T; Alouache S; Tazir M; Gautier V; Arlet G; Bakour R
    Pathol Biol (Paris); 2008 Jul; 56(5):319-25. PubMed ID: 18585867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates.
    Lin SP; Liu MF; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):200-7. PubMed ID: 22209695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
    Decré D; Burghoffer B; Gautier V; Petit JC; Arlet G
    J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and updating of the Osiris expert system for identification of Escherichia coli beta-lactam resistance phenotypes.
    Bert F; Juvin M; Ould-Hocine Z; Clarebout G; Keller E; Lambert N; Arlet G
    J Clin Microbiol; 2005 Apr; 43(4):1846-50. PubMed ID: 15815007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of beta-lactams resistance among Escherichia coli clinical isolates from a hospital in Algiers.
    Messai Y; Benhassine T; Naim M; Paul G; Bakour R
    Rev Esp Quimioter; 2006 Jun; 19(2):144-51. PubMed ID: 16964332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolates in faecal samples of broilers.
    Costa D; Vinué L; Poeta P; Coelho AC; Matos M; Sáenz Y; Somalo S; Zarazaga M; Rodrigues J; Torres C
    Vet Microbiol; 2009 Sep; 138(3-4):339-44. PubMed ID: 19372011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strategies to overcome extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases in shigellae.
    Livermore DM; Mushtaq S; Nguyen T; Warner M
    Int J Antimicrob Agents; 2011 May; 37(5):405-9. PubMed ID: 21276715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66).
    Wu JJ; Chen HM; Ko WC; Wu HM; Tsai SH; Yan JJ
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):169-75. PubMed ID: 17913434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
    Shi WF; Zhou J; Qin JP
    Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
    Apfalter P; Assadian O; Daxböck F; Hirschl AM; Rotter ML; Makristathis A
    J Antimicrob Chemother; 2007 May; 59(5):854-9. PubMed ID: 17347178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I; Tóth A; Pászti J; Hajbel-Vékony G; Jakab M; Berta J; Milch H; Füzi M
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.
    Nucleo E; Fugazza G; Migliavacca R; Spalla M; Comelli M; Pagani L; Debiaggi M
    New Microbiol; 2010 Jan; 33(1):37-45. PubMed ID: 20402412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study.
    Brasme L; Nordmann P; Fidel F; Lartigue MF; Bajolet O; Poirel L; Forte D; Vernet-Garnier V; Madoux J; Reveil JC; Alba-Sauviat C; Baudinat I; Bineau P; Bouquigny-Saison C; Eloy C; Lafaurie C; Siméon D; Verquin JP; Noël F; Strady C; De Champs C
    J Antimicrob Chemother; 2007 Nov; 60(5):956-64. PubMed ID: 17804424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
    Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program.
    Wang JT; Chen PC; Chang SC; Shiau YR; Wang HY; Lai JF; Huang IW; Tan MC; Lauderdale TL;
    BMC Infect Dis; 2014 Sep; 14():486. PubMed ID: 25192738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.